Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Sep;74(3):972–975. doi: 10.1172/JCI111517

Central cholinergic stimulation causes adrenal epinephrine release.

B Kennedy, D S Janowsky, S C Risch, M G Ziegler
PMCID: PMC425255  PMID: 6470148

Abstract

Cholinergic drugs administered into the cerebral ventricles of animals selectively stimulate the adrenal medulla. However, the effects of central cholinergic stimulation on the sympathoadrenal system have not been studied in man. We stimulated central cholinergic activity in man by administering the cholinesterase inhibitor physostigmine to subjects pretreated with peripheral cholinergic blocking agents. A dose of 0.022 mg/kg physostigmine dramatically increased plasma epinephrine levels and slightly increased norepinephrine levels, which is consistent with selective adrenomedullary stimulation. A smaller dose of physostigmine increased epinephrine but did not alter norepinephrine levels. Subjects had increased pulse rates and blood pressures, and felt anxious while they had high plasma epinephrine levels.

Full text

PDF
972

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aquilonius S. M., Sjöström R. Cholinergic and dopaminergic mechanisms in Huntington's chorea. Life Sci I. 1971 Apr 1;10(7):405–414. doi: 10.1016/0024-3205(71)90146-9. [DOI] [PubMed] [Google Scholar]
  2. Best J. D., Halter J. B. Release and clearance rates of epinephrine in man: importance of arterial measurements. J Clin Endocrinol Metab. 1982 Aug;55(2):263–268. doi: 10.1210/jcem-55-2-263. [DOI] [PubMed] [Google Scholar]
  3. Brezenoff H. E. Centrally induced pressor responses to intravenous and intraventricular physostigmine evoked via different pathways. Eur J Pharmacol. 1973 Sep;23(3):290–292. doi: 10.1016/0014-2999(73)90097-6. [DOI] [PubMed] [Google Scholar]
  4. Brezenoff H. E., Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol. 1982;22:341–381. doi: 10.1146/annurev.pa.22.040182.002013. [DOI] [PubMed] [Google Scholar]
  5. Buccafusco J. J., Spector S. Role of central cholinergic neurons in experimental hypertension. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):347–355. doi: 10.1097/00005344-198007000-00002. [DOI] [PubMed] [Google Scholar]
  6. Bühler F. R., Amann F. W., Bolli P., Hulthén L., Kiowski W., Landmann R., Bürgisser E. Elevated adrenaline and increased alpha-adrenoceptor-mediated vasoconstriction in essential hypertension. J Cardiovasc Pharmacol. 1982;4 (Suppl 1):S134–S138. doi: 10.1097/00005344-198200041-00027. [DOI] [PubMed] [Google Scholar]
  7. COHEN G., HOLLAND B., SHA J., GOLDENBERG M. Plasma concentrations of epinephrine and norepinephrine during intravenous infusions in man. J Clin Invest. 1959 Nov;38:1935–1941. doi: 10.1172/JCI103972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Caputi A. P., Camilleri B. H., Brezenoff H. E. Age-related hypotensive effect of atropine in unanesthetized spontaneously hypertensive rats. Eur J Pharmacol. 1980 Aug 22;66(1):103–109. doi: 10.1016/0014-2999(80)90300-3. [DOI] [PubMed] [Google Scholar]
  9. Dimsdale J. E., Moss J. Short-term catecholamine response to psychological stress. Psychosom Med. 1980 Sep;42(5):493–497. doi: 10.1097/00006842-198009000-00003. [DOI] [PubMed] [Google Scholar]
  10. Durrett L. R., Ziegler M. G. A sensitive radioenzymatic assay for catechol drugs. J Neurosci Res. 1980;5(6):587–598. doi: 10.1002/jnr.490050613. [DOI] [PubMed] [Google Scholar]
  11. Fiorica V., Galloway D. C., Males J. L., Painton R. P., Kem D. C. Epinephrine fraction of adrenal vein blood in pheochromocytoma. Am J Med Sci. 1982 Nov-Dec;284(3):9–15. doi: 10.1097/00000441-198211000-00002. [DOI] [PubMed] [Google Scholar]
  12. Fisher D. A., Brown M. R. Somatostatin analog: plasma catecholamine suppression mediated by the central nervous system. Endocrinology. 1980 Sep;107(3):714–718. doi: 10.1210/endo-107-3-714. [DOI] [PubMed] [Google Scholar]
  13. Franco-Morselli R., Baudouin-Legros M., Meyer P. Plasma adrenaline and noradrenaline in essential hypertension and after long-term treatment with beta-adrenoreceptor-blocking agents. Clin Sci Mol Med Suppl. 1978 Dec;4:97s–100s. doi: 10.1042/cs055097s. [DOI] [PubMed] [Google Scholar]
  14. Helke C. J., Muth E. A., Jacobowitz D. M. Changes in central cholinergic neurons in the spontaneously hypertensive rat. Brain Res. 1980 Apr 28;188(2):425–436. doi: 10.1016/0006-8993(80)90042-6. [DOI] [PubMed] [Google Scholar]
  15. Johnson T. S., Young J. B., Landsberg L. Sympathoadrenal responses to acute and chronic hypoxia in the rat. J Clin Invest. 1983 May;71(5):1263–1272. doi: 10.1172/JCI110876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krstić M. K., Djurković D. Cardiovascular response to intracerebroventricular administration of acetylcholine in rats. Neuropharmacology. 1978 Jun;17(6):341–347. doi: 10.1016/0028-3908(78)90004-7. [DOI] [PubMed] [Google Scholar]
  17. Kubo T., Tatsumi M. Increased pressor responses to physostigmine in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):81–83. doi: 10.1007/BF00515597. [DOI] [PubMed] [Google Scholar]
  18. Molinoff P. B., Weinshilboum R., Axelrod J. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep;178(3):425–431. [PubMed] [Google Scholar]
  19. ROTHBALLER A. B. Studies on the adrenaline-sensitive component of the reticular activating system. Electroencephalogr Clin Neurophysiol. 1956 Nov;8(4):603–621. doi: 10.1016/0013-4694(56)90084-0. [DOI] [PubMed] [Google Scholar]
  20. Risch S. C., Kalin N. H., Janowsky D. S. Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates. J Clin Psychopharmacol. 1981 Jul;1(4):186–192. doi: 10.1097/00004714-198107000-00003. [DOI] [PubMed] [Google Scholar]
  21. STARK P., BOYD E. S. EFFECTS OF CHOLINERGIC DRUGS ON HYPOTHALAMIC SELF-STIMULATION RESPONSE RATES OF DOGS. Am J Physiol. 1963 Oct;205:745–748. doi: 10.1152/ajplegacy.1963.205.4.745. [DOI] [PubMed] [Google Scholar]
  22. VARAGIC V. The action of eserine on the blood pressure of the rat. Br J Pharmacol Chemother. 1955 Sep;10(3):349–353. doi: 10.1111/j.1476-5381.1955.tb00882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Young J. B., Fish S., Landsberg L. Sympathetic nervous system and adrenal medullary responses to ischemic injury in mice. Am J Physiol. 1983 Jul;245(1):E67–E73. doi: 10.1152/ajpendo.1983.245.1.E67. [DOI] [PubMed] [Google Scholar]
  24. Young J. B., Landsberg L. Sympathoadrenal activity in fasting pregnant rats. Dissociation of adrenal medullary and sympathetic nervous system responses. J Clin Invest. 1979 Jul;64(1):109–116. doi: 10.1172/JCI109429. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES